Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.
Uyttenhove C; Pilotte L; Théate I; Stroobant V; Colau D; Parmentier N; Boon T; Van den Eynde BJ; Nature Medicine, 2003, vol. 9, issue 10, p 1269, ISSN 10788956. ISBN 10788956.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef